Related Experiment Video

Updated: Oct 28, 2026

Intravital Imaging of Attenuated Auxotrophic Mycobacterium tuberculosis in Murine Lung during Early Intravascular Infection
14:26

Intravital Imaging of Attenuated Auxotrophic Mycobacterium tuberculosis in Murine Lung during Early Intravascular Infection

Published on: June 30, 2026

Mycotic pulmonary arterial aneurysms in an intravenous drug user

L McLean1, S Sharma, B Maycher

  • 1Departments of Internal Medicine and Radiology, University of Manitoba, Winnipeg, Canada.

Canadian Respiratory Journal
|October 6, 1998
PubMed

Insights

Mycotic pulmonary artery aneurysms (PAA) in intravenous drug users can resolve with conservative therapy. This case highlights that even potentially fatal PAAs may improve without hemoptysis, suggesting less invasive management options.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Radiology

Background:

  • Mycotic pulmonary artery aneurysms (PAA) are rare but serious complications, particularly in intravenous drug users (IVDU).
  • The natural history and optimal management strategies for PAA remain incompletely understood.
  • Early diagnosis and intervention are crucial due to the high risk of rupture and mortality.

Observation:

  • A case study of a mycotic PAA in an IVDU is presented.
  • The aneurysm demonstrated resolution following a course of conservative management.
  • The patient did not experience hemoptysis, a significant clinical feature.

Findings:

  • Conservative therapy can lead to the resolution of mycotic PAAs.
  • Absence of hemoptysis may be a favorable prognostic indicator for non-surgical management.
  • This case contributes to understanding the potential for non-operative resolution in PAA.

Implications:

  • Conservative management should be considered for select PAA cases, especially in IVDU without hemoptysis.
  • Further research into the natural history and treatment outcomes of PAA is warranted.
  • Improved diagnostic and therapeutic algorithms for PAA can enhance patient survival and reduce morbidity.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...